1,859
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Association between recorded medication reviews in primary care and adequate drug treatment management – a cross-sectional study

, &
Pages 419-428 | Received 07 Mar 2021, Accepted 11 Aug 2021, Published online: 22 Sep 2021

References

  • Skjøt-Arkil H, Lundby C, Kjeldsen LJ, et al. Multifaceted pharmacist-led interventions in the hospital setting: a systematic review. Basic Clin Pharmacol Toxicol. 2018;123(4):363–379.
  • Huiskes VJ, Burger DM, van den Ende CH, et al. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract. 2017;18(1):5.
  • Ödesjö H, Anell A, Boman A, et al. Pay for performance associated with increased volume of medication reviews but not with less inappropriate use of medications among the elderly - an observational study. Scand J Prim Health Care. 2017;35(3):271–278.
  • Swedish National Board of Health and Welfare. Handling and prescribing of drugs in health care [HSLF-FS 2017:37. Socialstyrelsens föreskrifter och allmänna råd om ordination och hantering av läkemedel i hälso- och sjukvården]. 2017.
  • Lönnbro J, Wallerstedt SM. Clinical relevance of the STOPP/START criteria in hip fracture patients. Eur J Clin Pharmacol. 2017;73(4):499–505.
  • Khalil H, Bell B, Chambers H, et al. Professional, structural and organisational interventions in primary care for reducing medication errors. Cochrane Database Syst Rev. 2017;10(10):CD003942.
  • O'Mahony D, O'Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218.
  • Fastbom J, Johnell K. National indicators for quality of drug therapy in older persons: the Swedish experience from the first 10 years. Drugs Aging. 2015;32(3):189–199.
  • Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med. 2014;52(6):815–824.
  • Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861–875.
  • Pazan F, Kather J, Wehling M. A systematic review and novel classification of listing tools to improve medication in older people. Eur J Clin Pharmacol. 2019;75(5):619–625.
  • Parodi López N, Wallerstedt SM. Quality of prescribing in older people from a broad family physician perspective: a descriptive pilot study. BMJ Open. 2019;9(6):e027290.
  • Wallerstedt SM, Belfrage B, Fastbom J. Association between drug-specific indicators of prescribing quality and quality of drug treatment: a validation study . Pharmacoepidemiol Drug Saf. 2015;24(9):906–914.
  • Säfholm S, Bondesson Å, Modig S. Medication errors in primary health care records; a cross-sectional study in Southern Sweden. BMC Fam Pract. 2019;20(1):110.
  • Wallerstedt SM, Wettermark B, Hoffmann M. The first decade with the Swedish prescribed drug register - a systematic review of the output in the scientific literature. Basic Clin Pharmacol Toxicol. 2016;119(5):464–469.
  • Schmidt-Mende K, Hasselstrom J, Wettermark B, et al. General practitioners' and nurses' views on medication reviews and potentially inappropriate medicines in elderly patients - a qualitative study of reports by educating pharmacists. Scand J Prim Health Care. 2018;36(3):329–341.
  • Duncan P, Cabral C, McCahon D, et al. Efficiency versus thoroughness in medication review: a qualitative interview study in UK primary care. Br J Gen Pract. 2019;69(680):e190–e198.
  • Hedenrud TM, Svensson SA, Wallerstedt SM. "Psychiatry is not a science like others" - a focus group study on psychotropic prescribing in primary care. BMC Fam Pract. 2013;14:115.
  • Rashidian A, Omidvari AH, Vali Y, et al. Pharmaceutical policies: effects of financial incentives for prescribers. Cochrane Database Syst Rev. 2015;(8):CD006731.
  • Schmidt-Mende K, Andersen M, Wettermark B, et al. Educational intervention on medication reviews aiming to reduce acute healthcare consumption in elderly patients with potentially inappropriate medicines-a pragmatic open-label cluster-randomized controlled trial in primary care. Pharmacoepidemiol Drug Saf. 2017;26(11):1347–1356.
  • Lehnbom EC, Stewart MJ, Manias E, et al. Impact of medication reconciliation and review on clinical outcomes. Ann Pharmacother. 2014;48(10):1298–1312.
  • Alldred DP, Kennedy MC, Hughes C, et al. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016;2:CD009095.
  • Abbott RA, Moore DA, Rogers M, et al. Effectiveness of pharmacist home visits for individuals at risk of medication-related problems: a systematic review and meta-analysis of randomised controlled trials. BMC Health Serv Res. 2020;20(1):39.
  • Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9(9):CD008165.
  • Tecklenborg S, Byrne C, Cahir C, et al. Correction to: interventions to reduce adverse drug event-related outcomes in older adults: a systematic review and meta-analysis. Drugs Aging. 2020;37(2):147–147.
  • Holland R, Desborough J, Goodyer L, et al. Does pharmacist‐led medication review help to reduce hospital admissions and deaths in older people? a systematic review and meta‐analysis. Br J Clin Pharmacol. 2008;65(3):303–316.
  • Fernholm R, Wachtler C, Malm-Willadsen K, et al. Validation and initial results of surveys exploring perspectives on risks and solutions for diagnostic and medication errors in primary care in Sweden. Scand J Prim Health Care. 2020;38(4):381–390.
  • Carrier H, Zaytseva A, Bocquier A, et al. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France. Br J Gen Pract. 2019;69(681):e270–e278.